Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Briumvi (ublituximab-xiiy)
i
Other names:
TG-1101, LFB R603, LFBR 603, LFBR-603, EMAB-6, R603, TG20, TGTX-1101, LFB-R603
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(7)
News
Trials
Company:
Ildong, LFB SA, Neuraxpharm, TG Therap
Drug class:
CD20 inhibitor
Related drugs:
‹
rituximab (174)
obinutuzumab (68)
epcoritamab-bysp (11)
ofatumumab (8)
rituximab-pvvr (6)
rituximab-abbs (6)
rituximab/hyaluronidase (5)
Rixathon (rituximab biosimilar) (4)
EX103 (3)
ibritumomab tiuxetan (3)
mosunetuzumab-axgb (2)
rituximab-arrx (2)
IMM0306 (2)
IGM-2323 (2)
AR160 (2)
glofitamab-gxbm (1)
TQB2303 (rituximab biosimilar) (1)
IPH6501 (1)
odronextamab (1)
Ritucad (rituximab biosimilar) (1)
ACE1831 (0)
ACTR087 (0)
ALETA-001 (0)
AcellBia (rituximab biosimilar) (0)
ripertamab (0)
zuberitamab (0)
Avetux (rituximab biosimilar) (0)
B001 (0)
BAT4306F (0)
BI 695500 (rituximab biosimilar) (0)
BM-ca (0)
CHO-H01 (0)
CIMAbior (rituximab biosimilar) (0)
CM355 (0)
CMG1A46 (0)
DI Leu16 IL-2 (0)
(0)
GB241 (rituximab biosimilar) (0)
GB261 (0)
Halpryza (rituximab biosimilar) (0)
Hanlikon (rituximab biosimilar) (0)
Reditux (rituximab biosimilar) (0)
JHL1101 (rituximab biosimilar) (0)
JMT601 (0)
JNJ-8543 (0)
JS203 (0)
Kikuzubam (rituximab biosimilar) (0)
FBTA05 (0)
MIL62 (0)
MK-8808 (rituximab biosimilar) (0)
MT-3724 (0)
MabionCD20 (rituximab biosimilar) (0)
Mabtas (rituximab biosimilar) (0)
NAV-006 (0)
Novex (rituximab biosimilar) (0)
ocrelizumab (0)
PRO131921 (0)
PSB202 (0)
Retuxira (rituximab biosimilar) (0)
SAIT101 (rituximab biosimilar) (0)
SIBP-02 (rituximab biosimilar) (0)
TQB2825 (0)
TRU-015 (0)
veltuzumab (0)
IGN002 (0)
AME-133v (0)
XmAb13676 (0)
TG20 (rituximab biosimilar) (0)
rituximab (174)
obinutuzumab (68)
epcoritamab-bysp (11)
ofatumumab (8)
rituximab-pvvr (6)
rituximab-abbs (6)
rituximab/hyaluronidase (5)
Rixathon (rituximab biosimilar) (4)
EX103 (3)
ibritumomab tiuxetan (3)
mosunetuzumab-axgb (2)
rituximab-arrx (2)
IMM0306 (2)
IGM-2323 (2)
AR160 (2)
glofitamab-gxbm (1)
TQB2303 (rituximab biosimilar) (1)
IPH6501 (1)
odronextamab (1)
Ritucad (rituximab biosimilar) (1)
ACE1831 (0)
ACTR087 (0)
ALETA-001 (0)
AcellBia (rituximab biosimilar) (0)
ripertamab (0)
zuberitamab (0)
Avetux (rituximab biosimilar) (0)
B001 (0)
BAT4306F (0)
BI 695500 (rituximab biosimilar) (0)
BM-ca (0)
CHO-H01 (0)
CIMAbior (rituximab biosimilar) (0)
CM355 (0)
CMG1A46 (0)
DI Leu16 IL-2 (0)
(0)
GB241 (rituximab biosimilar) (0)
GB261 (0)
Halpryza (rituximab biosimilar) (0)
Hanlikon (rituximab biosimilar) (0)
Reditux (rituximab biosimilar) (0)
JHL1101 (rituximab biosimilar) (0)
JMT601 (0)
JNJ-8543 (0)
JS203 (0)
Kikuzubam (rituximab biosimilar) (0)
FBTA05 (0)
MIL62 (0)
MK-8808 (rituximab biosimilar) (0)
MT-3724 (0)
MabionCD20 (rituximab biosimilar) (0)
Mabtas (rituximab biosimilar) (0)
NAV-006 (0)
Novex (rituximab biosimilar) (0)
ocrelizumab (0)
PRO131921 (0)
PSB202 (0)
Retuxira (rituximab biosimilar) (0)
SAIT101 (rituximab biosimilar) (0)
SIBP-02 (rituximab biosimilar) (0)
TQB2825 (0)
TRU-015 (0)
veltuzumab (0)
IGN002 (0)
AME-133v (0)
XmAb13676 (0)
TG20 (rituximab biosimilar) (0)
›
Associations
(7)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Chronic Lymphocytic Leukemia
No biomarker
Chronic Lymphocytic Leukemia
umbralisib + ublituximab-xiiy
Sensitive: B - Late Trials
umbralisib + ublituximab-xiiy
Sensitive
:
B
umbralisib + ublituximab-xiiy
Sensitive: B - Late Trials
umbralisib + ublituximab-xiiy
Sensitive
:
B
Chr del(17p)
Chronic Lymphocytic Leukemia
Chr del(17p)
Chronic Lymphocytic Leukemia
ibrutinib + ublituximab-xiiy
Sensitive: B - Late Trials
ibrutinib + ublituximab-xiiy
Sensitive
:
B
ibrutinib + ublituximab-xiiy
Sensitive: B - Late Trials
ibrutinib + ublituximab-xiiy
Sensitive
:
B
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
ibrutinib + ublituximab-xiiy
Sensitive: B - Late Trials
ibrutinib + ublituximab-xiiy
Sensitive
:
B
ibrutinib + ublituximab-xiiy
Sensitive: B - Late Trials
ibrutinib + ublituximab-xiiy
Sensitive
:
B
Chr del(11q)
Chronic Lymphocytic Leukemia
Chr del(11q)
Chronic Lymphocytic Leukemia
ibrutinib + ublituximab-xiiy
Sensitive: B - Late Trials
ibrutinib + ublituximab-xiiy
Sensitive
:
B
ibrutinib + ublituximab-xiiy
Sensitive: B - Late Trials
ibrutinib + ublituximab-xiiy
Sensitive
:
B
IL2 elevation
Mantle Cell Lymphoma
IL2 elevation
Mantle Cell Lymphoma
umbralisib + ublituximab-xiiy + TG-1701
Sensitive: D – Preclinical
umbralisib + ublituximab-xiiy + TG-1701
Sensitive
:
D
umbralisib + ublituximab-xiiy + TG-1701
Sensitive: D – Preclinical
umbralisib + ublituximab-xiiy + TG-1701
Sensitive
:
D
IL6 elevation
Mantle Cell Lymphoma
IL6 elevation
Mantle Cell Lymphoma
umbralisib + ublituximab-xiiy + TG-1701
Sensitive: D – Preclinical
umbralisib + ublituximab-xiiy + TG-1701
Sensitive
:
D
umbralisib + ublituximab-xiiy + TG-1701
Sensitive: D – Preclinical
umbralisib + ublituximab-xiiy + TG-1701
Sensitive
:
D
TNFA elevation
Mantle Cell Lymphoma
TNFA elevation
Mantle Cell Lymphoma
umbralisib + ublituximab-xiiy + TG-1701
Sensitive: D – Preclinical
umbralisib + ublituximab-xiiy + TG-1701
Sensitive
:
D
umbralisib + ublituximab-xiiy + TG-1701
Sensitive: D – Preclinical
umbralisib + ublituximab-xiiy + TG-1701
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login